Japanese sushi chain boss resigns amid accusation of improper data access
Although the sales data was shared among parent company Kappa Create employees, local mediaOther stolen data allegedly included procurement costs and suppliers, details or food quantities and planned campaigns. The head of product department at Kappa Create was also arrested, as he allegedly shared the data internally.
Hama Sushi revealed the leak during a January 2021 investigation and filed a report with the police department, which resulted in raids on Kappa Create headquarters.[PDF] that Tanabe had resigned “on the grounds of being arrested and detained for violation of the law. The company offered “deepest apologies,” vowed to fully cooperate with the sushi scandal investigation, and offered that it was already conducting compliance training for officers and employees.
Growing worldwide demand for fish, a weaker yen and global events such as the crisis in Ukraine have led to an increase in prices at sushi restaurants, especially those operating on lean margins. The ¥100 sushi conveyor-belt plate, a concept originally introduced by Kappa Sushi, is a mainstay of such establishments but now appears to be on its way out. For example, competitor Sushiro recently raised its plate prices to ¥120, reported
Profits for conveyor-belt sushi in times of such lean margins rely on securing the best prices from suppliers, who often change prices, so understanding a competitor’s agreements could be useful.his deed to local media and said whether he had committed a crime or not was “a matter of contention.”put it, it's hard to imagine someone doing hard time for “chopstick wholesale price data,” but that may just be a sign of the times.
Danmark Seneste Nyt, Danmark Overskrifter
Similar News:Du kan også læse nyheder, der ligner denne, som vi har indsamlet fra andre nyhedskilder.
4 ways to protect your period tracking dataNow more than ever, vigilance is key when it comes to your period-related data - here are some tips to keep you safe online
Læs mere »
US-UK Data Access Agreement now in effect for tackling crimeFrom today, America and UK follow new rules on how they can demand your data from each other
Læs mere »
Warning as viral iPhone scam can trick users into downloading dangerous softwareExperts are warning iPhone users about an 'especially common' scam which could compromise their private data.
Læs mere »
Teradata CTO pours cold water on lakehouse conceptTeradata CTO Stephen Brobst drowns data lakehouse concept
Læs mere »
Transparency and reporting characteristics of COVID-19 randomized controlled trials - BMC MedicineBackground In the context of the COVID-19 pandemic, randomized controlled trials (RCTs) are essential to support clinical decision-making. We aimed (1) to assess and compare the reporting characteristics of RCTs between preprints and peer-reviewed publications and (2) to assess whether reporting improves after the peer review process for all preprints subsequently published in peer-reviewed journals. Methods We searched the Cochrane COVID-19 Study Register and L·OVE COVID-19 platform to identify all reports of RCTs assessing pharmacological treatments of COVID-19, up to May 2021. We extracted indicators of transparency (e.g., trial registration, data sharing intentions) and assessed the completeness of reporting (i.e., some important CONSORT items, conflict of interest, ethical approval) using a standardized data extraction form. We also identified paired reports published in preprint and peer-reviewed publications. Results We identified 251 trial reports: 121 (48%) were first published in peer-reviewed journals, and 130 (52%) were first published as preprints. Transparency was poor. About half of trials were prospectively registered (n=140, 56%); 38% (n=95) made their full protocols available, and 29% (n=72) provided access to their statistical analysis plan report. A data sharing statement was reported in 68% (n=170) of the reports of which 91% stated their willingness to share. Completeness of reporting was low: only 32% (n=81) of trials completely defined the pre-specified primary outcome measures; 57% (n=143) reported the process of allocation concealment. Overall, 51% (n=127) adequately reported the results for the primary outcomes while only 14% (n=36) of trials adequately described harms. Primary outcome(s) reported in trial registries and published reports were inconsistent in 49% (n=104) of trials; of them, only 15% (n=16) disclosed outcome switching in the report. There were no major differences between preprints and peer-reviewed publications. Of the 130
Læs mere »
Bank of England had a heavy week. Now for analytics in cloudData more essential than ever, says analytics chief as Liz Truss U-turns on tax, and world+dog remembers Bank's there to manage risk
Læs mere »